Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 7/20 | 0.71 |
| ▸ | FNTB | P49356 | 7/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.57 |
| ▸ | RORC | P51449 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4301678 | 0.93 | FNTA (0.71) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL5755699 | 0.87 | FNTA (0.72) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL12038529 | 0.84 | FNTA (0.86) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL4303894 | 0.84 | FNTA (0.71) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL6329801 | 0.83 | FNTA (0.72) | FNTAFNTBRORC | |
| SCHEMBL11947190 | 0.83 | FNTA (0.75) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL11947195 | 0.83 | FNTA (0.77) | FNTAFNTBCYP3A4RORC | |
| SCHEMBL13928075 | 0.83 | FNTA (1.00) | FNTAFNTBCYP3A4 | |
| SCHEMBL1682772 | 0.83 | FNTA (1.00) | FNTAFNTBCYP3A4 | |
| SCHEMBL5758107 | 0.83 | FNTA (0.60) | FNTAFNTBCYP3A4RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6844357-B2 | Substituted quinolin-2-one derivatives useful as antiproliferative agents | PFIZER INC. (US) | 2005-01-18 | — | — | US | claimed |
| US-6841603-B1 | Polymer blends containing polyhydroxyalkanoates and compositions with good retention of elongation | METABOLIX, INC. (US) | 2005-01-11 | — | — | US | claimed |
| US-20030166675-A1 | Substituted quinolin-2-one derivatives useful as antiproliferative agents | PFIZER INC. | 2003-09-04 | — | — | US | claimed |
| US-6844357-B2 | Substituted quinolin-2-one derivatives useful as antiproliferative agents | PFIZER INC. (US) | 2005-01-18 | — | — | US | disclosed |
| US-20030166675-A1 | Substituted quinolin-2-one derivatives useful as antiproliferative agents | PFIZER INC. | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166675-A1 | Substituted quinolin-2-one derivatives useful as antiproliferative agents | CCNA1, NRAS, CCNA2 | FNTA 2022/4885FNTB 3123/4885CYP3A4 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.